Introduction
As the global population of elderly adults rapidly increases, the incidence of neurocognitive disorders will triple to 152 million by 2050, making it the most severe health challenge facing humanity in the 21st century.1 A research study in 2012 shows that the social cost incurred by patients with neurocognitive disorders almost equals the combined costs of cancer, heart disease and stroke.2 3 There are no reversals for this degenerative illness, but early standard intervention could maximise patients’ quality of life and reduce the burden of the disease. Alzheimer’s disease (AD) is the most common type of neurocognitive disorder. In 2017, Livingston et al reviewed the risk factors for AD. They believed it was possible to prevent AD by promoting sports and social interaction, reducing depression and implementing cognitive training measures.4 Therefore, identifying risk factors of older adults and implementing interventions to address them may be an effective means to reduce the incidence of the disease, or at least its severity. Mild cognitive impairment (MCI) is a transitional state between normal ageing and early dementia. The prevalence of MCI in older adults aged 60 years or above in China ranges from 15.5% to 27.8%, and the proportion of MCI progressing to AD within 5 years is 10%–15% every year.5 6
However, today in China, cognitive disorder screening, diagnosis and intervention remain deficient. Few intervention methods are known and carried out by older adults with MCI or subjective cognitive decline (SCD). There are several reasons for this. First, elderly persons in Chinese communities do not actively participate in available intervention offerings because of insufficient awareness of cognitive impairment. For example, one study in Shanghai showed that 45% of people believed that ‘dementia is a normal part of ageing’, and only 30% of those interviewed knew the necessity for medical treatment.7 8 Second, cognitive disorders have not been included in policies that address the daily management of chronic diseases and are not prioritised by community physicians in primary medical and health institutions that lack cognitive screening and diagnostic technology. Studies abroad have shown that the sensitivity of community doctors for the diagnosis of mild dementia is only 0.14–0.330.9 Third, professionals and institutions in geriatric psychiatry and neurology tend only to treat and care for patients with dementia more severe than MCI and SCD. Finally, because there is a lack of effective drug treatments, the public have low expectations for treatment benefits,10 which leads to decreased hope and searching for disease treatment and intervention.
Based on the barriers and practical significance of early-stage screening and intervention, we developed a comprehensive cognitive health management method focusing on strengthening health management with risk factor-targeted recommendations by medical professionals in community settings. In this study, we selected elderly residents over 60 years of age in multiple communities in Shanghai for cognitive function screening, conducted comprehensive cognitive health management for a portion of those with normal cognition (NC) and MCI, and then explored the effect on cognitive function. Finally, we sought to verify whether this early-intervention method could be promoted in Chinese communities.